The Effect of Prenatal Hand Expression on the Rate of Exclusive Breastfeeding to Two Months

NCT ID: NCT05066438

Last Updated: 2021-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

176 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-30

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite recommendations by several health authorities, the rate of sustained exclusive breastfeeding for two months is less than fifty-five percent in Canada. The two most common reasons for early discontinuation are problems with milk supply and difficulty with technique. Antenatal hand expression (AHE) is a method used to assist with colostrum collection in low-risk pregnancies near term. This method has been shown to have several benefits, including increased milk supply at birth. This study aims to determine if the employment of antenatal hand expression in low-risk pregnancies near term affects the rate of sustained breastfeeding exclusively to two months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breastfeeding Breastfeeding, Exclusive Breast Milk Collection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Antenatal hand expression - intention to exclusively breastfeed

Eligible participants in this group intend to exclusively breastfeed AND must have received standardized counselling on and practiced antenatal hand expression for a minimum of 10 days beginning no earlier than 36 weeks gestational age.

Antenatal hand expression

Intervention Type BEHAVIORAL

Standardized counselling and provision of information/resources on the practice of antenatal hand expression to encourage milk let down and colostrum production/collection.

No antenatal hand expression - intention to exclusively breastfeed

Eligible participants in this group intend to exclusively breastfeed but have NOT received any standardized counselling on antenatal hand expression and have not practiced antenatal hand expression OR have practiced antenatal hand expression but for less than 10 days.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Antenatal hand expression

Standardized counselling and provision of information/resources on the practice of antenatal hand expression to encourage milk let down and colostrum production/collection.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* inclusion to breastfeed
* no contraindications to vaginal delivery
* multiple gestation only if cleared for vaginal delivery

Exclusion Criteria

* intention to formula feed
* antenatal hand expression training provided by staff outside of study protocol
* practiced antenatal hand expression prior to 36 weeks gestation
* breech presentation
* history of preterm labour, preterm birth or threatened preterm labour
* history of (or current) cervical insufficiency
* any contraindication to vaginal delivery (ie. placenta or vasa previa, classical uterine scar, etc.)
* intrauterine growth restriction
* antepartum hemorrhage
* any contraindication to breastfeeding (eg. HIV)
* multiple gestation requiring Cesarean delivery
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Saskatchewan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Almereau Prollius

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Almereau Prollius, MD

Role: PRINCIPAL_INVESTIGATOR

University of Saskatchewan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Naida Hawkins, RN

Role: CONTACT

3068437421

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Bio 2238

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.